Free tool
FAERS Monitor: Lioresal
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020075 or its brand name (Lioresal, Baclofen). Reports on generic versions are filed under their own applications.
Reports
85,287
Serious
56,425
66% of reports
Hospitalization
28,021
Death reported
6,381
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue6,308
- drug ineffective5,651
- pain5,558
- fall5,455
- nausea4,695
- headache4,449
- gait disturbance4,137
- off label use3,870
- dizziness3,632
- urinary tract infection3,527
- asthenia3,445
- multiple sclerosis relapse3,424
- muscle spasms3,280
- diarrhoea3,162
- vomiting2,874
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 646 |
| 2005 | 757 |
| 2006 | 675 |
| 2007 | 795 |
| 2008 | 886 |
| 2009 | 1,033 |
| 2010 | 1,500 |
| 2011 | 1,741 |
| 2012 | 2,516 |
| 2013 | 3,027 |
| 2014 | 4,252 |
| 2015 | 5,157 |
| 2016 | 7,596 |
| 2017 | 7,024 |
| 2018 | 7,705 |
| 2019 | 6,672 |
| 2020 | 5,778 |
| 2021 | 5,486 |
| 2022 | 5,099 |
| 2023 | 5,673 |
| 2024 | 4,226 |
| 2025 | 4,065 |
| 2026 | 2,975 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,968,872 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| multiple sclerosis relapseSignal | 3,424 | 12.9 | 12.5 | 35,866 |
| gait disturbanceSignal | 4,137 | 5.4 | 5.3 | 14,743 |
| urinary tract infectionSignal | 3,527 | 5.2 | 5.0 | 11,761 |
| muscle spasmsSignal | 3,280 | 4.5 | 4.3 | 8,749 |
| fallSignal | 5,455 | 4.1 | 4.0 | 12,738 |
| astheniaSignal | 3,445 | 2.3 | 2.2 | 2,471 |
| painSignal | 5,558 | 2.2 | 2.2 | 3,905 |
| fatigueSignal | 6,308 | 2.0 | 2.0 | 3,278 |
| dizziness | 3,632 | 1.8 | 1.7 | 1,317 |
| headache | 4,449 | 1.8 | 1.7 | 1,479 |
| vomiting | 2,874 | 1.5 | 1.5 | 504 |
| nausea | 4,695 | 1.5 | 1.4 | 717 |
| diarrhoea | 3,162 | 1.2 | 1.2 | 117 |
| off label use | 3,870 | 1.1 | 1.1 | 30 |
| drug ineffective | 5,651 | 1.1 | 1.0 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.